RAPID MICRO BIOSYSTEMS, INC. — Director's Dealing 2021

Jul 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK: 0001380106
Period of Report: 2021-07-19

Reporting Person: Kollender Richard S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-19	Class A Common Stock	C	1315084	—	Acquired	1373193	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-19	Series A1 Preferred Stock	$	C	4623796	Disposed		Class A Common Stock (924759)	Indirect
2021-07-19	Series B1 Preferred Stock	$	C	1130906	Disposed		Class A Common Stock (226180)	Indirect
2021-07-19	Series C1 Preferred Stock	$	C	820729	Disposed		Class A Common Stock (164145)	Indirect
2021-07-19	Series A1 Warrant	$0.01	C	410051	Disposed	2027-07-24	Series A1 Preferred Stock (410051)	Indirect
2021-07-19	Common Stock Warrant	$0.05	C	82010	Acquired	2027-07-24	Class A Common Stock (82010)	Indirect
2021-07-19	Series B1 Warrant	$0.01	C	64516	Disposed	2028-01-17	Series B1 Preferred Stock (64516)	Indirect
2021-07-19	Common Stock Warrant	$0.05	C	12903	Acquired	2028-01-17	Class A Common Stock (12903)	Indirect
2021-07-19	Series B1 Warrant	$0.01	C	64516	Disposed	2027-12-06	Series B1 Preferred Stock (64516)	Indirect
2021-07-19	Common Stock Warrant	$0.05	C	12903	Acquired	2027-12-06	Class A Common Stock (12903)	Indirect

Footnotes

F1: The Series A1 Preferred Stock, the Series B1 Preferred Stock and the Series C1 Preferred Stock (collectively, the "Preferred Stock") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering.

F2: These shares are held directly by Quaker Bioventures II, L.P. The Reporting Person is a managing director of Quaker Bioventures Capital II, L.P., the parent of Quaker Bioventures II, L.P. and may be deemed to beneficially hold the shares.

F3: The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.

F4: Immediately exercisable.